PRASAD MANIAN to Treatment Outcome
This is a "connection" page, showing publications PRASAD MANIAN has written about Treatment Outcome.
Connection Strength
0.026
-
Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial. Lancet Respir Med. 2023 09; 11(9):791-803.
Score: 0.017
-
An early aggressive strategy for the treatment of Hanta virus cardiopulmonary syndrome: a perspective from an extracorporeal membrane oxygenation center. Clin Infect Dis. 2014 Aug 01; 59(3):458-9.
Score: 0.009